Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study
Shinozaki, Eiji, Yoshino, Takayuki, Yamazaki, Kentaro, Muro, Kei, Yamaguchi, Kensei, Nishina, Tomohiro, Yuki, Satoshi, Shitara, Kohei, Bando, Hideaki, Mimaki, Sachiyo, Nakai, Chikako, Matsushima, KoutТом:
117
Мова:
english
Журнал:
British Journal of Cancer
DOI:
10.1038/bjc.2017.308
Date:
November, 2017
Файл:
PDF, 523 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
